Zydus Cadila gets final approval from USFDA for Decitabine Injection
Zydus Cadila has received final approval from the U.S. Food and Drug Administration (USFDA) to market Decitabine for Injection in the strength of 50 mg/vial Single-Dose Vial (USRLD: Dacogen). Decitabine is used to treat myelodysplastic syndromes, certain types of blood or bone marrow cancer. The drug will be manufactured at the group’s injectables manufacturing facility … Read more
